Endometriosis

Karlotta M. Davis, John A. Rock
In: Current Opinion in Obstetrics and Gynecology · 1992 · vol. 4(2) , pp. 229–237 · doi:10.1097/00001703-199204000-00007 · W4245576261
article OA: closed CC0 ⤵ 3 in-corpus citations
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This review discusses diagnostic advancements, a new classification system, pathophysiology including autoimmune theories, laparoscopic and medical treatment options, and emerging immunomodulatory therapies for endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Recent advances in endometriosis research are reviewed. Factors relating to the increasing frequency of laparoscopic diagnosis as well as potential diagnostic tests utilizing endometrial antibody and CA 125 assays of both serum and peritoneal fluids are discussed. A new classification is proposed that takes into consideration depth of endometriotic lesions. The pathophysiology of endometriosis is an area of increased research activity with attention directed toward autoimmune theories of impaired surveillance. A variety of autoantibodies have been found to be increased in patients with endometriosis, and peritoneal macrophage activation is also thought to play a role. Laparoscopic treatment options are reviewed, including investigations of various laser methods as well as electrocautery. Medical therapy comparing various gonadotropin-releasing hormone agonists and danazol and the effects of these treatment options on bone density are presented. New directions in immunomodulatory drug therapy are discussed.
Full text 1,070 characters · extracted from oa-doi-fallback · click to expand
Endometriosis - Karlotta M. Davis - John A. Rock Recent advances in endometriosis research are reviewed. Factors relating to the increasing frequency of laparoscopic diagnosis as well as potential diagnostic tests utilizing endometrial antibody and CA 125 assays of both serum and peritoneal fluids are discussed. A new classification is proposed that takes into consideration depth of endometriotic lesions. The pathophysiology of endometriosis is an area of increased research activity with attention directed toward autoimmune theories of impaired surveillance. A variety of autoantibodies have been found to be increased in patients with endometriosis, and peritoneal macrophage activation is also thought to play a role. Laparoscopic treatment options are reviewed, including investigations of various laser methods as well as electrocautery. Medical therapy comparing various gonadotropin-releasing hormone agonists and danazol and the effects of these treatment options on bone density are presented. New directions in immunomodulatory drug therapy are discussed.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK